Spring til hovednavigation
Spring til søgning
Spring til hovedindhold
Sorter
Keyphrases
30-day Mortality
7%
95% Confidence Interval
53%
Absolute Risk
6%
Acute Coronary Syndrome
7%
Adult Patients
8%
Adverse Events
6%
Affective Disorders
7%
All-cause Mortality
22%
Anesthesia
8%
Antidepressants
6%
Atrial Fibrillation
18%
Bipolar Disorder
24%
Body Mass Index
7%
C-reactive Protein
6%
Capital Region
7%
Cardiovascular Disease
9%
Cardiovascular Events
7%
Cardiovascular Mortality
10%
Cardiovascular Risk Factors
8%
Chronic Kidney Disease
11%
Chronic Obstructive Pulmonary Disease
14%
Clinical Outcomes
8%
Clinical Practice
8%
Clinical Trials
6%
Colorectal Cancer
6%
Community-acquired Pneumonia
11%
Comorbidity
16%
Confidence Interval
18%
Continuous Glucose Monitoring
10%
Copenhagen
9%
COVID-19
44%
Critically Ill Patients
6%
Crohn's Disease
9%
Danish Population
7%
Denmark
100%
Diabetes
19%
During Pregnancy
12%
Europe
7%
Gestational Age
7%
Glucagon-like
7%
Hazard Ratio
29%
Health-related Quality of Life
11%
Healthcare Professionals
6%
Healthy Controls
10%
Heart Failure
23%
Hemoglobin A1c (HbA1c)
15%
High Risk
15%
Hospital Admission
7%
Hospitalization
19%
Hospitalized Patients
9%
Hypoglycemia
33%
Incidence Rate
14%
Inflammatory Bowel Disease
16%
Insulin
9%
Intensive Care Unit
15%
Intensive Care Unit Patients
11%
Ischemic Heart Disease
6%
Ischemic Stroke
6%
Liraglutide
6%
Major Depressive Disorder
7%
Meta-analysis
21%
Mortality Rate
6%
Mortality Risk
10%
Myocardial Infarction
16%
National Cohort Study
50%
Nationwide Registers
8%
Nationwide Registry
17%
Newly Diagnosed
10%
Non-associated
8%
Odds Ratio
19%
Out-of-hospital Cardiac Arrest
24%
Patients with Diabetes
10%
Physical Activity
9%
Placebo
22%
Population-based Cohort Study
6%
Population-based Study
8%
Pre-diabetes (pre-DM)
7%
Pregnant Women
11%
Prospective Cohort Study
16%
Quality of Life
16%
Randomized Clinical Trial
22%
Randomized Controlled Trial
33%
Randomized Placebo-controlled Trial
13%
Randomized Trial
10%
Register Study
11%
Register-based
7%
Relative Risk
6%
Respiratory Syncytial Virus
9%
Retrospective Cohort Study
9%
Risk Factors
25%
Septic Shock
7%
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
11%
Severe Hypoglycemia
17%
Type 1 Diabetes Mellitus (T1DM)
53%
Type 2 Diabetes Mellitus (T2DM)
25%
Type 2 Diabetic Patients
16%
Type I Diabetes
48%
Ulcerative Colitis
7%
Venous Thromboembolism
8%
Without Diabetes
6%
Medicine and Dentistry
Acute Coronary Syndrome
9%
Adolescence
12%
Adverse Event
12%
All Cause Mortality
12%
Antibiotic Therapy
6%
Antibiotics
7%
Antidiabetic Agent
8%
Apoplexy
13%
Arm
7%
Atrial Fibrillation
14%
Awareness
7%
Biological Marker
13%
Bipolar Disorder
13%
Bleeding
8%
Blood Pressure
6%
Body Mass Index
11%
Cardiovascular Disease
17%
Cardiovascular System
25%
Case-Control Study
7%
Cesarean Section
12%
Chronic Kidney Disease
10%
Chronic Obstructive Pulmonary Disease
12%
Clinical Trial
8%
Clinician
6%
Cohort Analysis
89%
Cohort Studies
6%
Colon Carcinoma
7%
Colorectal Carcinoma
9%
Community-Acquired Pneumonia
9%
Comorbidity
16%
Computer Assisted Tomography
8%
Congestive Heart Failure
27%
Coronary Angiography
6%
Coronary Artery Disease
8%
COVID-19
36%
Crohn's Disease
9%
Cross Sectional Study
8%
Diabetes
38%
Diabetes Mellitus
10%
Diseases
31%
Education
7%
First Trimester Pregnancy
6%
Glucagon-Like Peptide-1 Agonist
6%
Glucose
22%
Hazard Ratio
24%
Health Care Cost
9%
Health Care Personnel
6%
Hemoglobin A1c
12%
Hip Arthroplasty
7%
Human Immunodeficiency Virus
9%
Hypoglycemia
35%
Infection
23%
Infective Endocarditis
6%
Inflammatory Bowel Disease
16%
Insulin
24%
Insulin Dependent Diabetes Mellitus
41%
Intensive Care
7%
Intensive Care Unit
21%
Knee Arthroplasty
6%
Logistic Regression Analysis
10%
Long-Term Outcome
8%
Low Drug Dose
7%
Lung
8%
Magnetic Resonance Imaging
7%
Malignant Neoplasm
12%
Maturity Onset Diabetes of the Young
27%
Meta-Analysis
13%
Morbidity
12%
Mortality Rate
6%
Myocardial Infarction
14%
Observational Study
15%
Obstetrics
6%
Odds Ratio
19%
Offspring
6%
Oral
13%
Out of Hospital Cardiac Arrest
21%
Outpatient
11%
Patient with Type 1 Diabetes
9%
Patient with Type 2 Diabetes
13%
Pediatrics
9%
Physical Activity
7%
Placebo
25%
Pregnant Woman
8%
Prevalence
22%
Proportional Hazards Model
7%
Prospective Cohort Study
14%
Quality of Life
23%
Randomized Clinical Trials
20%
Randomized Controlled Trial
35%
Recurrent Disease
8%
Resuscitation
7%
Retrospective Cohort Study
9%
Septic Shock
7%
Severe Acute Respiratory Syndrome Coronavirus 2
12%
Severe Hypoglycemia
14%
Systematic Review
26%
Triage
7%
Tuberculosis
6%
Ulcerative Colitis
7%
Venous Thromboembolism
6%